Literature DB >> 21990375

A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.

Pascal Renner1, Thierry Roger, Pierre-Yves Bochud, Tom Sprong, Fred C G J Sweep, Murielle Bochud, Saul N Faust, Elene Haralambous, Helen Betts, Anne-Laure Chanson, Marlies Knaup Reymond, Elliot Mermel, Veronique Erard, Marcel van Deuren, Robert C Read, Michael Levin, Thierry Calandra.   

Abstract

Macrophage migration inhibitory factor (MIF) is an abundantly expressed proinflammatory cytokine playing a critical role in innate immunity and sepsis and other inflammatory diseases. We examined whether functional MIF gene polymorphisms (-794 CATT(5-8) microsatellite and -173 G/C SNP) were associated with the occurrence and outcome of meningococcal disease in children. The CATT(5) allele was associated with the probability of death predicted by the Pediatric Index of Mortality 2 (P=0.001), which increased in correlation with the CATT(5) copy number (P=0.04). The CATT(5) allele, but not the -173 G/C alleles, was also associated with the actual mortality from meningoccal sepsis [OR 2.72 (1.2-6.4), P=0.02]. A family-based association test (i.e., transmission disequilibrium test) performed in 240 trios with 1 afflicted offspring indicated that CATT(5) was a protective allele (P=0.02) for the occurrence of meningococcal disease. At baseline and after stimulation with Neisseria meningitidis in THP-1 monocytic cells or in a whole-blood assay, CATT(5) was found to be a low-expression MIF allele (P=0.005 and P=0.04 for transcriptional activity; P=0.09 and P=0.09 for MIF production). Taken together, these data suggest that polymorphisms of the MIF gene affecting MIF expression are associated with the occurrence, severity, and outcome of meningococcal disease in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990375     DOI: 10.1096/fj.11-195065

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  29 in total

Review 1.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

2.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

3.  Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.

Authors:  Jie Yao; Lin Leng; Maor Sauler; Weiling Fu; Junsong Zheng; Yi Zhang; Xin Du; Xiaoqing Yu; Patty Lee; Richard Bucala
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

4.  Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression.

Authors:  Hee Kyung Kim; Alvaro Baeza Garcia; Edwin Siu; Pathricia Tilstam; Rita Das; Scott Roberts; Lin Leng; Richard Bucala
Journal:  FASEB J       Date:  2019-02-28       Impact factor: 5.191

5.  Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.

Authors:  Rituparna Das; Meredith I LaRose; Christopher B Hergott; Lin Leng; Richard Bucala; Jeffrey N Weiser
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.

Authors:  Rituparna Das; Mi-Sun Koo; Bae Hoon Kim; Shevin T Jacob; Selvakumar Subbian; Jie Yao; Lin Leng; Rebecca Levy; Charles Murchison; William J Burman; Christopher C Moore; W Michael Scheld; John R David; Gilla Kaplan; John D MacMicking; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

7.  Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adults.

Authors:  Rituparna Das; Lakshman Subrahmanyan; Ivana V Yang; David van Duin; Rebecca Levy; Marta Piecychna; Lin Leng; Ruth R Montgomery; Albert Shaw; David A Schwartz; Richard Bucala
Journal:  J Infect Dis       Date:  2013-10-24       Impact factor: 5.226

Review 8.  MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity.

Authors:  Richard Bucala
Journal:  J Clin Immunol       Date:  2012-09-12       Impact factor: 8.317

9.  Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.

Authors:  M A Llamas-Covarrubias; Y Valle; R Bucala; R E Navarro-Hernández; C A Palafox-Sánchez; J R Padilla-Gutiérrez; I Parra-Rojas; A G Bernard-Medina; Z Reyes-Castillo; J F Muñoz-Valle
Journal:  Cytokine       Date:  2013-02-09       Impact factor: 3.861

10.  Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis.

Authors:  Rituparna Das; Kerry Loughran; Charles Murchison; Feng Qian; Lin Leng; Yan Song; Ruth R Montgomery; Mark Loeb; Richard Bucala
Journal:  Cytokine       Date:  2015-11-28       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.